Mirum Pharmaceuticals, Inc.
MIRM
Hisse Senetlerindeki Sıralama
#3249
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to... Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Hisse Fiyatı
$83.62
Son senkronizasyon: 2026-10-21
Piyasa Değeri
$5.43B
Değişim (1 gün)
-1.71%
Değişim (1 yıl)
20.14%
Ülke
US
Ticaret Mirum Pharmaceuticals, Inc. (MIRM)
Kategori
Healthcare
Mirum Pharmaceuticals, Inc. (MIRM) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $82.31 - 2026-10-01
Gün sonu en düşük fiyat: $13.66 - 2019-07-01
Gün sonu en düşük fiyat: $13.66 - 2019-07-01
Mirum Pharmaceuticals, Inc. için hisse fiyatı geçmişi: 2019 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2026 (TTM) | 28.91% |
| 2025 | 68.24% |
| 2024 | 35.06% |
| 2023 | 73.09% |
| 2022 | 24.19% |
| 2021 | -29.47% |
| 2020 | 29.71% |
| 2019 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.77 | -3.82% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
